🇺🇸 FDA
Patent

US 9468669

Methods to treat dysregulated blood glucose disorders

granted A61KA61K31/198A61K31/42

Quick answer

US patent 9468669 (Methods to treat dysregulated blood glucose disorders) held by Regents of the University of Minnesota expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Oct 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/198, A61K31/42, A61K38/28, A61K45/06